rheumatic%20fever%20-%20acute
RHEUMATIC FEVER - ACUTE
Acute rheumatic fever is an autoimmune response to a previous group A beta-hemolytic streptococcal (GAS) infection causing acute generalized anti-inflammatory response primarily affecting the heart.
It often presents in patients 5-14 years of age and uncommon before 3 years and after 21 years of age.
Patients presenting with acute rheumatic fever are severely unwell, in extreme pain and requires hospitalization.

Principles of Therapy

  • Give oral Phenoxymethylpenicillin upon suspicion of acute rheumatic fever (ARF) & during the course of diagnosis. Once diagnosis is established, administer Benzathine penicillin G & stop Phenoxymethylpenicillin

 Secondary Prevention
Recurrent ARF is defined as 2 major or 1 major w/ 2 minor or 3 minor manifestations plus evidence of previous GAS infection

  • Continuous antimicrobial prophylaxis is recommended in patients w/ history of rheumatic fever (RF)
  • Prophylaxis of 12 months duration w/ reevaluation thereafter is recommended for patients w/ possible RF
    • Reevaluation should include repeat history, physical exam & echocardiography

Pharmacotherapy

Anti-infectives

Amoxicillin

  • Used to eradicate or prevent Group A streptococcus (GAS) infection
  • Treatment option for patients w/ penicillin allergy

Benzathine Penicillin G

  • Given to eradicate streptococci & is the 1st dose of penicillin for secondary prophylaxis
  • Drug of choice for acute rheumatic fever (ARF) patients w/ confirmed GAS not allergic to Penicillin

Cephalosporins

  • Eg Cephalexin, Cefadroxil
  • Used for the primary prevention & treatment of GAS infection in patients allergic to Penicillin

Macrolides, Oral

  • Eg Erythromycin, Clindamycin, Clarithromycin, Azithromycin, Roxithromycin
  • Used if patient has documented penicillin allergy
  • Recommended once there is suspicion of ARF & continue for 10 days or until ARF is diagnosed & Benzathine penicillin G is administered

Phenoxymethylpenicillin (Penicillin V), Oral

  • Used to eradicate GAS infection, if present
  • Start administration once there is suspicion of ARF & continue for 10 days or until ARF is diagnosed & Benzathine penicillin G is administered

Symptomatic Pharmacotherapy

Rheumatologists, cardiologists, &/or neurologists should be consulted based on the patient’s symptoms. Use of NSAID, salicylates &/or steroids are not recommended until ARF is confirmed as it will prevent development of joint manifestations & suppress acute phase reactants

Arthritis

  • Salicylates & nonsteroidal anti-inflammatory drugs (NSAID)
    • Eg Aspirin, Codeine, Ibuprofen, Naproxen, Paracetamol
    • Used for arthritis or severe arthralgia
    • Paracetamol is recommended as first-line therapy for ARF arthritis pain
    • Naproxen is a treatment option for Aspirin, w/c is no longer advised in several countries due to its adverse effects (eg Reye’s syndrome)
    • Recommended once ARF is confirmed 
  • Analgesics
    • Paracetamol & codeine are used for arthritis or severe arthralgia if ARF is not yet confirmed & patient is still undergoing diagnosis
    • Patients w/ mild arthralgia respond well to Paracetamol

Carditis/Heart Failure

  • Diuretics (eg Furosemide, Spironolactone) are used for mild-moderate heart failure
  • Angiotensin-converting-enzyme (ACE) inhibitors (eg Captopril, Enalapril, Lisinopril) may be used for more severe  heart failure [dysfunctional left ventricular (LV) function]
  • Corticosteroids (eg Prednisone, Prednisolone) are indicated for severe carditis, heart failure, or pericarditis w/ effusion
  • Digoxin is administered if atrial fibrillation or heart failure is present
  • See Heart Failure Disease Management Chart in MIMS Cardiology

Sydenham’s chorea

  • Start pharmacotherapy when symptoms interfere w/ normal activities
    • Sedatives or anticonvulsants (eg Carbamazepine, Valproic Acid, Haloperidol, Chlorpromazine & Diazepam), may be used to relieve symptoms

Fever

  • Paracetamol is indicated for fever
Secondary Prevention
Benzathine Benzylpenicillin G
  • Recommended 1st-line antibiotic regimen for the prevention of recurrent RF
  • An intramuscular dose every 4 weeks is recommended

Anti-infectives, Oral

Phenoxymethylpenicillin

  • The only oral anti-infective recommended for the prevention of recurrent RF
  • 2nd-line antibiotic regimen for the prevention of ARF next to Penicillin G

Sulfadiazine or Sulfafurazole

  • Recommended only in patients allergic to penicillins

Macrolides

  • Erythromycin, Clarithromycin, or Azithromycin may be used in patients allergic to penicillins, sulfadiazine, & sulfafurazole

Duration of Prophylaxis

  • RF patients w/ persistent valvular disease should receive prophylaxis for 10 years or until 40 years old, whichever is longer
    • Lifelong prophylaxis may be recommended in high-risk patients
  • RF patients w/ carditis but no residual heart disease may receive prophylaxis for 10 years or until 21 years old, whichever is longer
  • RF patients w/o carditis may continue prophylaxis up to 5 years or until 21 years old, whichever is longer
  • Discontinuation of prophylaxis should be thoroughly discussed w/ the patient & his/her family w/ emphasis on risks vs benefits

Non-Pharmacological Therapy

Initial episode of acute rheumatic fever (ARF) requires hospitalization for thorough clinical assessment, observation & guided management

General care

  • Examine daily for pattern of arthritis, presence of heart murmur, choreiform movements, skin rash & subcutaneous nodules
  • Seek medical attention upon the 1st sign of pharyngitis
  • Document cardiac signs & symptoms w/ carditis
  • Educate & involve family members
Diet
  • Advise nutritious diet w/o restrictions except in patients w/ congestive heart failure (CHF)
    • Patients w/ CHF should follow a fluid-limited & sodium-restricted diet
  • Potassium supplementation may be necessary due to mineralocorticoid effect of corticosteroid & diuretics, if used

Bed rest & indoor ambulation

  • Recommended duration of bed rest
    • 1-2 weeks w/ arthritis alone
    • 2-3 weeks w/ mild carditis, 4-6 weeks w/ moderate carditis, 2-4 months w/ severe carditis
  • Recommended duration of indoor ambulation
    • 1-2 weeks after hospital discharge w/ arthritis alone
    • 2-3 weeks after hospital discharge w/ mild carditis, 4-6 weeks after hospital discharge w/ moderate carditis, 2-4 months after hospital discharge w/ severe carditis
  • Do not allow full activity until the C-reactive protein (CRP) & erythrocyte sedimentation rate (ESR) have returned to normal
  • Patients w/ Sydenham’s chorea may require a wheelchair & should be on homebound instruction until abnormal movements resolve
  • No physical restrictions are needed after the initial episode subsides in the absence of carditis
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
22 Oct 2017
Drinking coffee, whether caffeinated or decaffeinated, is associated with a reduced risk of cardiovascular disease (CVD) and ischaemic heart disease (IHD) mortality in patients with a prior myocardial infarction (MI), according to a recent study.
23 Sep 2018
Supplementation with n−3 or omega-3 fatty acids does not help prevent serious vascular events in diabetic patients without evidence of cardiovascular disease at baseline, according to a study.
Roshini Claire Anthony, 11 Oct 2018

The risk of hospitalization due to heart failure was almost halved in patients with secondary mitral regurgitation who underwent transcatheter mitral valve repair plus medical therapy compared with those who underwent medical therapy alone, according to findings of the COAPT* trial.

07 Jan 2016

According to a Cochrane review, there is moderate evidence to show that fibrates can prevent myocardial infarction (MI) in patients with existing circulatory disease. [2015;10:CD009580. Doi:10.1002/14651858.CD009580.pub2]